Press releases
164 press releases
-
Gustave Roussy accelerate the development of innovative anticancer treatments by expanding its portfolio of privileged global partnerships
Gustave Roussy and AbbVie have entered into a three-year strategic scientific alliance aimed at accelerating the development of innovative cancer therapies.
-
Gustave Roussy and Takeda announce scientific partnership to advance innovative research programs in solid tumors and hematologic malignancies
Paris, 5 November 2026 – Gustave Roussy, the leading cancer center in both France and Europe and ranked third worldwide, and Takeda have announced a new scientific partnership. This long...
-
ESMO 2026 - Addressing the side effects of endocrine therapy: a new care pathway combining digital support and human expertise
Dr Maria Alice Franzoi, medical oncologist and specialist in digital health and care pathway implementation, will present the results of the HOPE study at the ESMO Congress. This...
-
ESMO 2026 - Exploring the potential of immunotherapy in early-stage triple-negative breast cancer
Dr Joana Ribeiro, medical oncologist in the Drug Development Department at Gustave Roussy, will present the results of the POP-DURVA clinical trial at the ESMO Congress. Conducted within...
-
INTERCEPTION: The national pilot program for personalized cancer prevention among individuals at increased risk of cancer enters its operational phase with the enrollment of the first patients
The Interception program has reached a new milestone with the enrollment of its first patients as part of the national Article 51 pilot program. Rolled out over four years across seven...
-
After a breast cancer diagnosis, how can treatment be started more quickly?
Gustave Roussy is launching a new care pathway designed to accelerate the management of women recently diagnosed with breast cancer. It brings together, in a single day, the radiology...
-
Gold september: two new research programmes launched to tackle childhood cancers
Two of Gustave Roussy’s four new medical and scientific programmes are dedicated to childhood cancers. The first, DECRIPT, aims to improve understanding of the role played by genetics in...
-
Prof. Fabrice Barlesi reappointed at the head of Gustave Roussy, the leading cancer center in France and Europe
By order of Ms. Stéphanie Rist, Minister of Health, Families, Autonomy and Persons with Disabilities, dated 27 July 2026, Professor Fabrice Barlesi has been reappointed as Director...
8 results per page